一个框架来分类通过常规产前75克葡萄糖耐受性测试诊断出妊娠糖尿病的框架
1Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, Stony Brook University Health Sciences Center, Stony Brook, NY, USA.
概括
一个新的框架根据葡萄糖耐受性测试 (GTT) 结果对妊娠期糖尿病 (GDM) 进行分类. 较高的GDM等级表明仅通过饮食来控制血糖的可能性较低.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 临床诊断 临床诊断 临床诊断
背景情况:
- 妊娠期糖尿病 (GDM) 的诊断依赖于常规的产前查.
- 目前的GDM分类主要以治疗为基础,缺乏客观的严重程度指标.
- 需要一个客观的框架来分类GDM严重程度.
研究的目的:
- 开发一个客观的框架来对GDM进行分类.
- 使用75g口服葡萄糖耐受性测试 (GTT) 的结果进行分类.
- 为目前基于治疗的GDM分类提供替代方案.
主要方法:
- 一个分类框架 (第1至第4类) 是基于75克GTT的血糖异常而开发出来的.
- 追溯队列图审查,以评估饮食治疗在维持血糖目标方面的成功.
- 奇方位分析,以评估饮食治疗有效性的类别间差异.
主要成果:
- 研究群体被分为四个GDM类:第1类 (33%),第2类 (15%),第3类 (33%) 和第4类 (19%).
- 单独的饮食疗法在57%的第1类患者,22.5%的第2类患者,12.5%的第3类患者和8%的第4类患者中成功地维持了整个怀孕期间的血糖目标.
- 在单独饮食治疗的成功方面,在各类之间观察到有统计学意义的差异.
结论:
- 拟议的框架客观地使用GTT结果对GDM严重程度进行分类.
- 更高的GDM类与仅通过饮食成功控制血糖的可能性降低相关.
- 这种GDM分类框架为疾病严重程度提供了客观的代理.
更多相关视频
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
2.5K
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
10.9K
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:20Pathophysiology of Diabetes
917
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
917
01:15Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
187
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
187
01:15Hypoglycemia and Glucagon
254
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
254